The demand for Spirometers is primarily attributed to the global prevalence of respiratory disorders like asthma, COPD, cystic fibrosis, the growing aging population, and technological progress. All these factors will directly lead to a surge in the Spirometers market.

Las Vegas, USA, Feb. 23, 2022 (GLOBE NEWSWIRE) — Spirometers Market to Grow at a Significant CAGR of 9.30% by 2026, Examines DelveInsight

The demand for Spirometers is primarily attributed to the global prevalence of respiratory disorders like asthma, COPD, cystic fibrosis, the growing aging population, and technological progress. All these factors will directly lead to a surge in the Spirometers market.

DelveInsight’s Spirometers Market Insights and Forecast report provides the current and forecast Spirometers Market, upcoming innovation in the devices, individual market shares, challenges, drivers, and barriers, market trends, and key competitors in the Spirometers Market.

Some of the essential factors from the Spirometers Market report:

• As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth and occupy the largest share in the Spirometers market.

• Key Spirometers companies proactively developing novel devices include names such as Hill Rom, Inc., Teleflex Incorporated, Vyaire Medical Inc., Fukuda Sangyo Co., Ltd., Chest M.I., Inc., Midmark Corporation, Futuremed USA, COSMED, MGC Diagnostics Corporation, NDD Medical Technologies, Schiller AG, MIR, Sibelmed, Smiths Medical PLC, Vitalograph, Jones Medical Instrument Company, Contec Medical Systems Co., Ltd., Medikro Oy, Clarity Medical, KoKo PFT and others.

• DelveInsight analyzes that Global Spirometers Market was valued at USD 943.74 million in 2020, growing at a CAGR of 9.30% during the forecast period from 2021 to 2026, is anticipated to reach USD 1,588.32 million by 2026.

• In July 2021, Tidal Medical Technologies announced that the US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for emergency use of the InSee incentive spirometer accessory for quantitatively tracking patient usage of Vyaire Medical’s AirLife incentive spirometer, as an aid in the treatment of respiratory conditions by patients with COVID-19 in hospital settings.

• In January 2020, US FDA approved NuvoAir’s connected spirometer device. Air Next is designed for patients with respiratory conditions such as asthma, COPD, and cystic fibrosis. Respiratory monitor maker NuvoAir (formerly Pond Healthcare Innovation) has picked up its first FDA 510(k) for Air Next, a portable and connected home-use spirometer device.

• In September 2020, a medical breath analysis company, Bedfont Scientific launched an incentive spirometer, Breathacise.

Story continues

To pick on the latest highlights related to Spirometers, get the snapshot of the key highlights entailed in the Spirometers Medical Device Report

Spirometers Overview

Spirometers are devices used to determine the amount of air exhaled and inhaled by the lungs during respiratory treatment. Spirometers measure how much air can be breathed in and out of the lungs, as well as how easy and fast it may be able to blow the air out of the lungs. Spirometry is suggested if a person is suffering from wheezing, shortness of breath, or a cough.

Spirometers Market Insight

Geographically, the Global Spirometers market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America currently leads the Global Spirometers market and is expected to remain constant during the forecast period. This domination is due to the high adoption of technological advancements and the improved reimbursement policies owing to the rise in healthcare expenditure by the US government.

Europe and Asia-Pacific region have the future potential growth for the Global Spirometers market. This is owing to the rising burden of the geriatric population in the European region countries and Asian countries. Rising product launch and commercialization agreements among the key manufacturers and other companies in the region are expected to boost the market. For instance, the launch of the Uscom digital ultrasonic SpiroSonic AIR spirometer has received European CE mark approval on May 2021, in the region by Uscom (UCM), such launces and approvals are expected to propel the growth of the market of Spirometers in the region.

Click here to understand more about the Spirometers Market Landscape @ Novel Developments In Spirometers Landscape

Spirometers Market Dynamics

Some of the key factors that are expected to drive the Spirometers market are rapid urbanization, increase in disposable income, improved government funding towards chronic disorders management, and growing awareness about early diagnosis of diseases. Also, rising respiratory diseases such as cystic fibrosis, COPD, and asthma, and their early diagnosis for effective and efficient management can propel the Spirometers market. Moreover, developed healthcare infrastructure, strong adoption of advanced technologies, the growing aging population, and the technological progress towards smartphone-based data acquisition will also promote the growth of the Spirometers Market.

Since the beginning of the COVID-19 pandemic, the demand for portable Spirometers has been on the rise. Portable spirometers provide accurate measurements as compared to those obtained from laboratory spirometers, and high-quality tracings can be achieved both at home healthcare and in the office setting. Also, Portable spirometers are an important contribution to epidemiologic and clinical studies that require frequent measures of a more broad range of pulmonary function parameters than can be provided by peak flowmeters. Therefore, the growing demand for disease treatment benefits the segment growth of the Spirometers market.

Get a sneak peek at the Spirometers market dynamics @ Spirometers Market Drivers Analysis

Scope of the Spirometers Market Report

• Coverage: Global

• Study Period: 2021-2026

• Market Segmentation By Type – Table-Top, Portable

• Market Segmentation By Technology – Volume Measurement, Flow Measurement

• Market Segmentation Based on Application – Asthma, COPD, Cystic Fibrosis, Others

• Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World

• Key Spirometers Companies – Hill Rom, Inc., Teleflex Incorporated, Vyaire Medical Inc., Fukuda Sangyo Co., Ltd., Chest M.I., Inc., Midmark Corporation, Futuremed USA, COSMED, MGC Diagnostics Corporation, NDD Medical Technologies, Schiller AG, MIR, Sibelmed, Smiths Medical PLC, Vitalograph, Jones Medical Instrument Company, Contec Medical Systems Co., Ltd., Medikro Oy, Clarity Medical, KoKo PFT and others.

• Porter’s Five Forces Analysis

• Product Profiles

• Case Studies

• KOL’s Views

• Analyst’s View

Delveinsight Analysis: Global Spirometers Market was valued at USD 943.74 million in 2020, growing at a CAGR of 9.30% during the forecast period from 2021 to 2026, to reach USD 1,588.32 million by 2026.

Know more about which MedTech player is set to emerge as the trendsetter @ Key Spirometers Companies Analysis

Table of Contents

Learn more about the report offerings @ Spirometers Regulatory And Patent Analysis

Pulse Oximeters Market

DelveInsight’s ‘Pulse Oximeters – Market Insights, Competitive Landscape and Market Forecast – 2026’ report delivers an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers and key Pulse Oximeters companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.

Cough Assist Devices Market

“DelveInsight’s ‘Cough Assist Devices – Market Insight, Competitive Landscape and Market Forecast, 2026’ report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key Cough Assist Devices companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.

Acute Respiratory Distress Syndrome Pipeline

DelveInsight’s, “Acute Respiratory Distress Syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 60+ companies and 60+ pipeline drugs in the Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key Acute Respiratory Distress Syndrome companies involved like Faron Pharmaceuticals, BioMarck Pharmaceuticals, Athersys, Apeiron Biologics, Cynata Therapeutics, Orbsen Therapeutics, GEn1E Lifesciences, Exvastat, Longeveron, CohBar, ZyVersa Therapeutics, Abbreos, Aviceda Therapeutics, ImStem Biotechnology, Bayer and many more.

Chronic Obstructive Pulmonary Disease Pipeline

DelveInsight’s, “Chronic Obstructive Pulmonary Disease – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products, and key Chronic Obstructive Pulmonary Disease companies involved like GlaxoSmithKline, Sanofi, Chiesi Farmaceutici S.p.A, United Therapeutics Corporation, Verona Pharma plc, AstraZeneca, Immunotek, Novartis, Genentech, Vertex Pharmaceuticals, Glenmark Pharmaceuticals, EmeraMed, Afimmune, 3SBio, OmniSpirant, Rhizen Pharmaceuticals, Foresee Pharmaceuticals, Brickell Biotech and many more.

Artificial Lung Devices Pipeline

DelveInsight’s, “Artificial Lung Devices–Pipeline Insight and Competitive Landscape, 2021,” report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the artificial lung devices pipeline landscape which includes key artificial lung devices companies like Lung Biotechnology, Miromatrix, Charles Stark Draper Laboratory Inc, United Therapeutics Corporation, XVIVO Perfusion, Medtronic, Getinge, Xenios AG, ALung Technologies Inc., MC3 Cardiopulmonary, Abiomed and many more.

Positive Airway Pressure Device Market

DelveInsight’s Positive Airway Pressure Device – Market Insight, Competitive Landscape and Market Forecast, 2026 report delivers an in-depth understanding of the market and Competitive Landscape analysis. Key Positive Airway Pressure companies involved in this market include Apex Medical Corp., Armstrong Medical Inc., Becton, Dickinson and Company, BMC Medical Co., Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Inc., Dymedso Inc., Fisher & Paykel Healthcare Limited, Invacare Corporation, and others

Airway Stents Market

DelveInsight’s Airway Stent – Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of the market and Competitive Landscape analysis. Key Airway stents companies involved in this market include Boston Medical Products, TAEWOONG Medical Co., Boston Scientific Corporation, Novatech SA, among others

Interested to know more about the breakthrough happenings? Take a look at the posts below

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

CONTACT: Contact Us Shruti Thakur info@delveinsight.com +1(919)321-6187 www.delveinsight.com